Cargando…

The Role of m(6)A Modification and m(6)A Regulators in Esophageal Cancer

SIMPLE SUMMARY: N(6)-methyladenosine (m(6)A) modification and m(6)A regulators play important roles in the occurrence and development of various cancers. Esophageal cancer (ESCA), one of the most common gastrointestinal tumors, seriously affects people’s health. In this review article, we summarized...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yuekao, Niu, Chaoxu, Wang, Na, Huang, Xi, Cao, Shiru, Cui, Saijin, Chen, Tianyu, Huo, Xiangran, Zhou, Rongmiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600289/ https://www.ncbi.nlm.nih.gov/pubmed/36291923 http://dx.doi.org/10.3390/cancers14205139

Ejemplares similares

CD39-Expressing CD8(+) T Cells as a New Molecular Marker for Diagnosis and Prognosis of Esophageal Squamous Cell Carcinoma
por: Liu, Meitong, et al.
Publicado: (2023)

Psoriasis Increased the Risk of Adverse Cardiovascular Outcomes: A New Systematic Review and Meta-Analysis of Cohort Study
por: Liu, Lu, et al.
Publicado: (2022)

Corrigendum: Psoriasis Increased the Risk of Adverse Cardiovascular Outcomes: A New Systematic Review and Meta-Analysis of Cohort Study
por: Liu, Lu, et al.
Publicado: (2022)

The implications of N6-methyladenosine (m6A) modification in esophageal carcinoma
por: He, Cheng, et al.
Publicado: (2023)

The role of N(6)-methyladenosine (m(6)A) modification in the regulation of circRNAs
por: Zhang, Lele, et al.
Publicado: (2020)

Recent advances of m(6)A methylation modification in esophageal squamous cell carcinoma
por: Zhang, Xiaoqing, et al.
Publicado: (2021)

Dynamic regulation and functions of mRNA m6A modification
por: Wang, Shanshan, et al.
Publicado: (2022)

N(6)‐methyladenosine (m(6)A) RNA modification in human cancer
por: Huo, Fu‐Chun, et al.
Publicado: (2020)

The role of m(6)A and m(6)Am RNA modifications in the pathogenesis of diabetes mellitus
por: Benak, Daniel, et al.
Publicado: (2023)

The Role of m6A Ribonucleic Acid Modification in the Occurrence of Atherosclerosis
por: Fu, Jie, et al.
Publicado: (2021)

The role of m(6)A modification in physiology and disease
por: Yang, Chuan, et al.
Publicado: (2020)

Aberrant Regulation of mRNA m(6)A Modification in Cancer Development
por: Luo, Junyun, et al.
Publicado: (2018)

The potential roles of m(6)A modification in regulating the inflammatory response in microglia
por: Li, Qi, et al.
Publicado: (2021)

The role of M(6)A modification in the regulation of tumor-related lncRNAs
por: Lan, Yufei, et al.
Publicado: (2021)

The Roles and Regulation of m(6)A Modification in Glioblastoma Stem Cells and Tumorigenesis
por: Li, Peng, et al.
Publicado: (2022)

Multiple Roles of m6A RNA Modification in Translational Regulation in Cancer
por: Fernandez Rodriguez, Guillermo, et al.
Publicado: (2022)

Regulatory Role of N6-methyladenosine (m(6)A) Modification in Osteosarcoma
por: Zhang, Yujie, et al.
Publicado: (2021)

Regulatory Role of N6-Methyladenosine (m6A) Modification in Osteoarthritis
por: Zhai, Ganggang, et al.
Publicado: (2022)

The Complex Roles and Therapeutic Implications of m(6)A Modifications in Breast Cancer
por: Wei, Min, et al.
Publicado: (2021)

Crosstalk Between Histone and m(6)A Modifications and Emerging Roles of m(6)A RNA Methylation
por: Xu, Zibin, et al.
Publicado: (2022)

Epigenetic Regulation of m(6)A Modifications in Human Cancer
por: Zhao, Wei, et al.
Publicado: (2019)

Regulation of Gene Expression by m6Am RNA Modification
por: Cesaro, Bianca, et al.
Publicado: (2023)

Epigenetic modification of m(6)A regulator proteins in cancer
por: Wang, Yumin, et al.
Publicado: (2023)

The Role of m6A Regulator-Mediated Methylation Modification and Tumor Microenvironment Infiltration in Glioblastoma Multiforme
por: Wang, Liang, et al.
Publicado: (2022)

Dynamic m(6)A modification regulates local translation of mRNA in axons
por: Yu, Jun, et al.
Publicado: (2018)

Risk of COVID-19 infection, hospitalization and mortality in psoriasis patients treated with interleukin-17 inhibitors: A systematic review and meta-analysis
por: Liu, Meitong, et al.
Publicado: (2022)

The role of m6A modification in the biological functions and diseases
por: Jiang, Xiulin, et al.
Publicado: (2021)

Role of Hakai in m(6)A modification pathway in Drosophila
por: Wang, Yanhua, et al.
Publicado: (2021)

The emerging roles of m(6)A modification in liver carcinogenesis
por: Pan, Xue-yin, et al.
Publicado: (2021)

Roles of m(6)A modification in oral cancer (Review)
por: Liu, Huimin, et al.
Publicado: (2022)

The Emerging Role of m6A Modification in Endocrine Cancer
por: Ji, Xiaoyu, et al.
Publicado: (2023)

RNA modification m(6)Am: the role in cardiac biology
por: Benak, Daniel, et al.
Publicado: (2023)

M6ADD: a comprehensive database of m(6)A modifications in diseases
por: Zhou, Dianshuang, et al.
Publicado: (2021)

Comparative Analysis of Human Genes Frequently and Occasionally Regulated by m(6)A Modification
por: Zhou, Yuan, et al.
Publicado: (2018)

The Emerging Role of m6A Modification in Regulating the Immune System and Autoimmune Diseases
por: Wang, Yimeng, et al.
Publicado: (2021)

Profiling of Transcriptome-Wide N6-Methyladenosine (m6A) Modifications and Identifying m6A Associated Regulation in Sperm Tail Formation in Anopheles sinensis
por: Liu, Congshan, et al.
Publicado: (2022)

Roles of N(6)‐methyladenosine (m(6)A) RNA modifications in urological cancers
por: Wang, Xiao, et al.
Publicado: (2020)

Emerging roles of N6-methyladenosine (m(6)A) modification in breast cancer
por: Wang, Yanyan, et al.
Publicado: (2020)

The Role of N(6)-Methyladenosine (m(6)A) Methylation Modifications in Hematological Malignancies
por: Zhao, Yan, et al.
Publicado: (2022)

Roles of N(6)-methyladenosine (m(6)A) modifications in gynecologic cancers: mechanisms and therapeutic targeting
por: Chen, Jiahua, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5mcqk7bis4io19p1lo8k8jitlo